Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-15
2008-04-15
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S556000
Reexamination Certificate
active
07358243
ABSTRACT:
This invention relates to novel diazabicyclononane and -decane derivatives useful as opioid receptor ligands. More specifically, the invention provides compounds useful as μ opioid receptor ligands.
REFERENCES:
patent: 5672601 (1997-09-01), Cignarella
patent: WO-00/66586 (2000-11-01), None
patent: WO-01/60823 (2001-08-01), None
patent: WO-01/72303 (2001-10-01), None
Razdan et al., “Studies on azabicyclo systems: synthesis and spasmolytic activity of analogues of 9-methyl-3,9-diazabicyclo[4.2.1]nonane and 10-methyl-3, 10-diazabicyclo[4.3.1]decane”, Eur. J. Med. Chem., vol. 22, 1987, pp. 573-577.
Nielsen Elsebet Østegaard
Olsen Gunnar M.
Peters Dan
Birch & Stewart Kolasch & Birch, LLP
Coleman Brenda L
NeuroSearch A/S
LandOfFree
Diazabicyclonane and-decane derivatives and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazabicyclonane and-decane derivatives and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazabicyclonane and-decane derivatives and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2747893